Table of Content

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Market Dynamics
3.1. Market Impacting Factors
3.1.1. Drivers
3.1.1.1. The increase in research and development by biopharmaceutical and pharmaceutical companies
3.1.2. Restraints:
3.1.2.1. High cost associated with the Organ Transplantation
3.1.2.2. Shortage in supply of organs
3.1.3. Opportunity
3.1.4. Impact Analysis
4. Industry Analysis
4.1. Porter’s Five Forces
4.2. Unmet Needs
4.3. Epidemiology
4.4. Supply chain Analysis
4.5. Regulatory Analysis
5. COVID-19 Analysis
5.1. Analysis of Covid-19 on the Market
5.1.1. Before COVID-19 Market Scenario
5.1.2. Present COVID-19 Market Scenario
5.1.3. After COVID-19 or Future Scenario
5.2. Pricing Dynamics Amid Covid-19
5.3. Demand-Supply Spectrum
5.4. Government Initiatives Related to the Market During Pandemic
5.5. Manufacturers Strategic Initiatives
5.6. Conclusion
6. By Technique
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
6.1.2. Market Attractiveness Index, By Technique
6.2. Static Cold Storage (SCS)
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Hypothermic Perfusion Preservation (HPP)
6.4. Normothermic Machine Perfusion
6.5. Others
7. By Preservation Solution
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
7.1.2. Market Attractiveness Index, By Preservation Solution
7.2. University of Wisconsin Solution (UW Solution)
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Custodiol HTK
7.4. Perfadex
7.5. Collins Solution
7.6. Citrate Solutions
7.7. Others
8. Organ Type
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Organ Type
8.1.2. Market Attractiveness Index, By Organ Type Segment
8.2. Kidneys
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Liver
8.4. Lung
8.5. Heart
8.6. Other Organs (Pancreas, Intestine)
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Specialty Clinics
9.4. Transplant Centres
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Italy
10.3.7.5. Spain
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. Australia
10.5.7.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technique
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Preservation Solution
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), Organ Type
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
10.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch
12. Company Profiles
12.1. Xvivo Perfusion AB
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. CryoLife, Inc.
12.3. Lifeline Scientific
12.4. BioTime, Inc.
12.5. Claris Lifesciences Limited
12.6. BioLife Solutions, Inc.
12.7. Dr. Franz Kohler Chemie GmbH
12.8. Bristol-Myers Squibb
12.9. Tolerotech, Inc.
12.10. 21st Century Medicine
LIST NOT EXHAUSTIVE
13. Global Organ Preservation Market– DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us